Tag: implanted device (cardiology)

Angiography Can Wait for Cardiac Arrest Without ST-Elevation

A protocol of immediate angiography provided no mortality benefit over a strategy or delayed or more selective angiography among patients resuscitated from out-of-hospital cardiac arrest...

1 Month DAPT Enough After High-Bleeding-Risk PCI

Another trial has added to the movement towards shortening the duration of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI). In the MASTER DAPT...

Repeat TAVR Central to Aortic Valve Disease Lifetime Strategy

Repeat transcatheter aortic valve replacement (TAVR), that is, TAVR performed within a failed TAVR valve, is associated with about half the short-term mortality of an...

First Risk Score to Predict Bleeding Risk After TAVR

A new clinical score has been developed, and externally validated, to identify patients at risk of bleeding after transcatheter aortic valve replacement (TAVR). “Despite the...

‘Thinner Strut’ Bioresorbable Scaffold Holds Own vs Mainstay DES

It was back to the drawing board for bioresorbable vascular scaffolds (BVS), to some degree, after the initially promising ABSORB series of trials dampened any...

Transradial Complex PCI Effective With Slim, Large-Bore Sheath

Transradial vascular access is often preferred over the transfemoral route in percutaneous coronary intervention (PCI) for its lower associated risks of bleeding and vascular complications....

Provisional Second Stent Shows Mettle in LM Bifurcations: EBC MAIN

Another randomized trial has compared two common approaches to stenting complex and challenging left-main (LM) coronary bifurcation lesions, and this one showed little difference between...

PASCAL Mitral Valve Repair Shines at 2 Years in CLASP

Transcatheter mitral valve repair with the PASCAL device showed high rates of survival and freedom from heart failure rehospitalization at 2 years in the single-arm,...

Switching From Ticagrelor to Clopidogrel Safe Post-PCI

New support for replacing higher-potency ticagrelor (Brilinta) with clopidogrel as part of dual-antiplatelet therapy (DAPT) 30 days after stenting for acute myocardial infarction comes from...

Paclitaxel Devices Exonerated in Real-World Data

A cohort analysis using advanced strategies to minimize the impact of confounders has concluded that the current Food and Drug Administration warning about paclitaxel-coated devices...

Ultrasound Renal Denervation Drops BP in Patients on Triple Therapy

Renal denervation’s comeback as a potential treatment for patients with drug-resistant hypertension rolls on. Renal denervation with ultrasound energy produced a significant, median 4.5–mm Hg...

Failed Transcatheter Mitral Repair Will Require Valve Replacement

In patients who had undergone transcatheter edge-to-edge (TEER) mitral valve repair and required reintervention, less than 5% underwent a surgical mitral valve repair rather than...

Patchy Growth of TAVR Programs Leaves Poorer Communities Behind

Inequities in the initial growth of transcatheter aortic valve replacement (TAVR) programs in American hospitals has led to less use of the transformative procedure in...

Target-Lesion Failure Reduced After MI With Biodegradable Stent

For a primary composite target-lesion failure outcome, a biodegradable polymer sirolimus-eluting stent showed superiority at 2 years over a durable polymer everolimus-eluting stent in patients...

BASILICA Technique Prevents TAVR-Related Coronary Obstruction

For patients undergoing transcatheter aortic valve replacement (TAVR), the intentional laceration technique of diseased valve leaflets called BASILICA is effective and reasonably safe for preventing...

Late-Window Stroke Thrombolysis Not Linked to Clot Migration

In patients with acute ischemic stroke, the use of thrombolysis in the late window of 4.5 to 9 hours after symptom onset was not associated...

Radial-to-Backup Artery Switch Adds Limited Risk in ACS PCI

There’s a price to pay for a failed radial artery attempt in invasively managed patients with acute coronary syndrome (ACS), but it may not be...

More, Larger Brain Lesions on MRI After Bicuspid TAVR

Diffusion-weighted MRI points to more silent brain injuries after transcatheter aortic valve replacement (TAVR) of bicuspid aortic valves (BAVs) in a single-center study. Although TAVR...

Renowned Interventional Cardiologist Dies of COVID-19

The interventional cardiology community is mourning the loss of Prof Anthony “Tony” Gershlick, MBBS, who died November 20 of COVID-19. He was 69. Gershlick was...

TAVR Surpasses SAVR in US, Outcomes Continue to Improve

Transcatheter aortic valve replacement (TAVR) has surpassed surgical aortic valve replacement (SAVR) as the procedure of choice for aortic valve replacement in the United States,...

Valvular Disease and COVID-19 Are a Deadly Mix; Don’t Delay Intervention

Editor’s note: Find the latest COVID-19 news and guidance in Medscape’s Coronavirus Resource Center. Danny Dvir, MD, has a message for physicians who have patients...

The ‘Grubby’ Affair of the EXCEL Trial and the European Guidelines

“I disapprove of what you say, but I will defend to the death your right to say it.” The choice of the secretary general of...

ACC Expert Consensus on Post-TAVR Arrhythmias

The American College of Cardiology (ACC) has released a new Expert Consensus Decision Pathway (ECDP) on the management of conduction disturbances after transcatheter aortic valve...

New SCOPE Data Put ACURATE neo on the Back Foot Again

ACURATE neo’s (Boston Scientific) place in the treatment of severe aortic stenosis is unclear after failing to show noninferiority in a head-to-head comparison with another...

More Support for Shorter DAPT in High Bleeding Risk PCI

Select high bleeding risk (HBR) patients can safely receive just 1 or 3 months of dual antiplatelet therapy (DAPT) after percutaneous coronary intervention (PCI) without...